| Your Current Location : Fund Card : Portfolio Classification |
 |
|
|
| |
| Bandhan Healthcare Fund IDCW |
| [Equity: Sectoral] |
|
| |
|
|
| Instruments Breakdown |
| Instruments |
Composition |
| Current Asset |
-0.23 |
| Equity |
95.88 |
| Trep |
4.35 |
|
| |
| Concentration Analysis |
| Top 5 Holdings |
39.30% |
| Top 10 Holdings |
60.53% |
| Top 25 Holdings |
91.39% |
|
|
|
| |
| Sector Analysis |
| Sector/Ratings |
Net Asset(%) |
| Pharma & Biotech |
63.87 |
| Healthcare |
29.33 |
| Cash |
4.12 |
| Miscellaneous |
2.4 |
| Software & Services |
0.28 |
|
|
|
|
|
| Portfolio Metrics |
|
| PB Ratio |
5.54 |
| PE Ratio |
40.00 |
|
| |
| Top 25 Holdings |
|
|
| Holdings |
Net Asset(%) |
| Sun Pharmaceutical Industries Limited |
9.34 |
| Apollo Hospitals Enterprise Limited |
8.67 |
| DIVI LABORATORIES LTD |
7.61 |
| Max Healthcare Institute Limited |
6.92 |
| Cipla Limited |
6.76 |
| Dr Reddys Laboratories Limited |
5.92 |
| J B Chemicals and Pharma Ltd |
4.57 |
| Triparty Repo TRP_040526 |
4.35 |
| Mankind Pharma Limited |
3.48 |
| Ajanta Pharma Limited |
2.91 |
| Aurobindo Pharma Limited |
2.87 |
| Lupin Limited |
2.78 |
| Dr Lal Path Labs Ltd |
2.73 |
| EQ- GLOBAL HEALTH LTD. |
2.69 |
| Glenmark Pharmaceuticals Limited |
2.32 |
| Syngene International Limited |
2.09 |
| Rainbow Childrens Medicare Limited |
1.94 |
| Abbott India Limited |
1.93 |
| Krishna Inst of Medical Sciences Ltd. |
1.84 |
| Glaxosmithkline Pharma Ltd |
1.77 |
| Shilpa Medicare Limited |
1.75 |
| Pfizer Limited |
1.62 |
| Eris Lifesciences Limited |
1.61 |
| Sai Life Sciences Limited |
1.47 |
| (5) Total outstanding exposure in derivative instruments as on April 30, 2026 is Rs. Nil. |
1.45 |
|
|
|
| |
|
| |
| Sector Analysis Graphical Mode |
|
| |
|
|
| |
|
 |
| |
|
|
|
